Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$122.47 - $213.56 $3,306 - $5,766
-27 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$185.52 - $231.25 $4,452 - $5,550
-24 Reduced 47.06%
27 $5,000
Q1 2020

May 15, 2020

BUY
$143.0 - $274.03 $143 - $274
1 Added 2.0%
51 $10,000
Q4 2019

Feb 14, 2020

BUY
$146.12 - $215.82 $7,306 - $10,791
50 New
50 $10,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.